Amicus Therapeutics
FOLD
FOLD was delisted on the 24th of April, 2026.
95 hedge funds and large institutions have $280M invested in Amicus Therapeutics in 2014 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 12 closing their positions.
292% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 12
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
106% more capital invested
Capital invested by funds: $136M → $280M (+$144M)
69% more call options, than puts
Call options by funds: $4.08M | Put options by funds: $2.41M
58% more funds holding
Funds holding: 60 → 95 (+35)
13% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$9.81M |
| 2 |
RIM
RS Investment Management
San Francisco,
California
|
+$6.54M |
| 3 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$6.45M |
| 4 |
Millennium Management
New York
|
+$6.11M |
| 5 |
D.E. Shaw & Co
New York
|
+$4.83M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$10.6M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$10.2M |
| 3 |
SEP
Sound Energy Partners
Greenwich,
Connecticut
|
-$2.11M |
| 4 |
UBS AM
Chicago,
Illinois
|
-$2.03M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$2M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
COPPSERS
101
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
| – | -$291K | -87,016 | Closed |
|
|
SFM
102
Soros Fund Management
New York
| – | -$235K | -70,500 | Closed |
|
|
SIP
103
Stoneridge Investment Partners
Radnor,
Pennsylvania
| – | -$161K | -48,064 | Closed |
|
|
HCM
104
Highbridge Capital Management
New York
| – | -$109K | -32,508 | Closed |
|
|
GC
105
Guggenheim Capital
Chicago,
Illinois
| – | -$56K | -16,717 | Closed |
|
106
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$2K | -740 | Closed |
|
107
BNP Paribas Financial Markets
Paris,
France
| – | -$107 | -32 | Closed |
|
FOLD Hedge Fund Activity: Q3 2014 in Review
95 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q3 2014, worth a combined $280M — up 106% from $136M a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new FOLD positions and 12 closed out — a net gain of 35 holders — while 18 added to existing stakes and 16 trimmed.
The largest buyer was Franklin Resources, opening a new position worth an estimated $9.81M. The largest seller was Palo Alto Investors, cutting an estimated $10.6M.
- 95 institutional investors held Amicus Therapeutics (FOLD) as of Q3 2014, up from 60 in Q2 2014.
- Funds reported $280M of Amicus Therapeutics stock for Q3 2014, up 106% quarter-over-quarter.
- 47 funds opened new Amicus Therapeutics positions in Q3 2014 and 12 closed out, a net change of +35 holders.
- The largest Amicus Therapeutics buyer in Q3 2014 was Franklin Resources, an estimated $9.81M added.
- The largest Amicus Therapeutics seller in Q3 2014 was Palo Alto Investors, an estimated $10.6M sold.
Based on aggregated 13F filings for Q3 2014.